小分子酪氨酸激酶抑制剂,TKI英语短句,例句大全

小分子酪氨酸激酶抑制剂,TKI
1)TKI小分子酪氨酸激酶抑制剂
1.Drugs targeting EGFR receptors have already been successfully implicated in clinic and all belong to two categories:monoclonal antibodies and tyrosine kinase inhibitors(TKIs).靶向EGFR家族的抗肿瘤药物可以分为单克隆抗体和小分子酪氨酸激酶抑制剂两大类。
2)Receptor tyrosine kinase inhibitor受体酪氨酸激酶抑制剂
1.Objective To explore the protective role of the receptor tyrosine kinase inhibitor in chondrocyte in vitro.目的通过对体外培养软骨细胞的实验研究,探寻受体酪氨酸激酶抑制剂对软骨细胞在细胞分子水平的影响及其可能机制。

英文短句/例句

1.Advances in the inhibitors of FLT-3 receptor tyrosine kinaseFLT-3受体酪氨酸激酶抑制剂的研究进展
2.Progress in research of multi-targeted inhibitors of receptor tyrosine kinase多靶点受体酪氨酸激酶抑制剂的研究进展
3.The inhibitor of VEGF receptor tyrosine kinase was introduced in detail.详细介绍了VEGF受体酪氨酸激酶抑制剂的研究进展。
4.The Effect of Receptor Tyrosine Kinase Inhibitor on Repair Tissue in Chondrocyte and Osteoarthritis Cartilage;受体酪氨酸激酶抑制剂在软骨修复中的作用研究
5.The Experimental Study on the Effect of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor on Polycystic Kidney Disease;表皮生长因子受体酪氨酸激酶抑制剂治疗多囊肾病的实验研究
6.Study of 4-AnilinoquinazoIines as Inhibitors of Tyrosine Kinase of the Epidermal Growth Factor Receptor;4-苯胺基喹唑啉类表皮生长因子受体酪氨酸激酶抑制剂的研究
7.Establishment of high throughput screening model for epidermal growth factor receptor tyrosine kinase inhibitor表皮生长因子受体酪氨酸激酶抑制剂高通量筛选模型的建立
8.The Therapeutic Effect of VEGF and PDGFB Receptor Tyrosine Kinases Inhibitors in Mice Corneal Angiogenesis;VEGF和PDGFB受体酪氨酸激酶抑制剂对小鼠角膜新生血管抑制作用的实验研究
9.The Effects of Combined Administration of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Cytotoxic Drugs in Different Tumor Cell Lines表皮生长因子受体酪氨酸激酶抑制剂联合化疗对不同肿瘤细胞株的作用
10.Project Epidermal Growth Factor Receptor Tyrosine Protein Kinase Inhibitor Screen Model;表皮生长因子受体酪氨酸蛋白激酶抑制剂筛选模型建立
11.Protein Tyrosine Kinase Inhibitor Genistein to Suppress Invasion of Human Lung Adenocarcinoma Cell Line A549 in vitro蛋白酪氨酸激酶抑制剂Genistein抑制肺癌细胞A549体外侵袭作用的研究
12.Metabolite identification of a novel antineoplastic of tyrosine kinase inhibitor,flumatinib,in chronic myelocytic leukemia patients酪氨酸激酶抑制剂抗肿瘤新药氟马替尼在人体内的代谢产物研究
13.Multi-targeted protein tyrosine kinase inhibitor:research advances多靶点蛋白酪氨酸激酶抑制剂的研究进展
14.Advances in the research of multi-target tyrosine kinase inhibitors多靶点抗肿瘤酪氨酸激酶抑制剂的研究开发
15.Effect of EGFR-TKI on Axonal Regeneration of Rabbit Facial Nerve in Regeneration Chamber: An Experimental Study;表皮生长因子受体酪氨酸酶抑制剂促进面神经再生的实验研究
16.Screen the Inhibitors of Protein Tyrosine Phosphatase 1B;蛋白质酪氨酸磷酸酶1B抑制剂的筛选
17.Synthesis and inhibition activity of 3-substituted indolin-2-ones as inhibitors of VEGFR-2 tyrosine kinaseVEGFR-2酪氨酸激酶抑制剂3-取代吲哚-2-酮的合成及抑制活性
18.Mechanism of drug resistance for chronic myeloid leukemia to BCR-ABL tyrosine kinase inhibitor慢性粒细胞白血病对BCR-ABL酪氨酸激酶靶向抑制剂的耐药机制

相关短句/例句

Receptor tyrosine kinase inhibitor受体酪氨酸激酶抑制剂
1.Objective To explore the protective role of the receptor tyrosine kinase inhibitor in chondrocyte in vitro.目的通过对体外培养软骨细胞的实验研究,探寻受体酪氨酸激酶抑制剂对软骨细胞在细胞分子水平的影响及其可能机制。
3)Tyrosine kinase inhibitors酪氨酸激酶抑制剂
1.Progress of epidermal growth factor receptor and tyrosine kinase inhibitors in the cancer therapy;表皮生长因子受体与酪氨酸激酶抑制剂在肿瘤防治中的应用进展
2.Recently, several approaches such as monoclonal an tibodies, bispecific antibodies, low molecular weight tyrosine kinase inhibitors and gene therapy targeting the EGFR family of receptors for anti-tumor therapy have been developed, some of which are currently undergoing clinical trials.近年来 ,许多以此为靶点的新的抗肿瘤药物和治疗方法陆续被开发 ,主要有单克隆抗体、双特异性抗体、小分子酪氨酸激酶抑制剂和基因治疗等。
4)Janus kinase 3 inhibitor酪氨酸激酶Jak3抑制剂
5)epidermal growth factor receptor tyrosine kinase inhibitorEGFR酪氨酸激酶抑制剂
1.Erlotinib,an epidermal growth factor receptor tyrosine kinase inhibitor;小分子EGFR酪氨酸激酶抑制剂盐酸埃罗替尼
6)tyrosine kinase inhibitor酪氨酸蛋白激酶抑制剂
1.Objective To assess the effect of tyrosine kinase inhibitor (2,5-MC) on the inhibition of in-stent inti-mal hyperplasia.目的评估酪氨酸蛋白激酶抑制剂2,5-MC抑制支架植入术后内膜增殖的效果。